enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Glipizide - Wikipedia

   en.wikipedia.org/wiki/Glipizide

   Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes. [1] [2] It is used together with a diabetic diet and exercise. [1] [2] It is not indicated for use by itself in type 1 diabetes. [1] [2] It is taken by mouth.

3. List of medical abbreviations: Latin abbreviations - Wikipedia

   en.wikipedia.org/wiki/List_of_medical...

   twice a day / twice daily bis in die gtt., gtts drop(s) gutta(e) h., h hour: hora: qhs, h.s., hs at bedtime or half strength quaque hora somni ii two tablets duos doses iii three tablets trēs doses n.p.o., npo, NPO nothing by mouth / not by oral administration: nil per os o.d., od, OD right eye. once a day (United Kingdom) oculus dexter omne ...

4. List of abbreviations used in medical prescriptions - Wikipedia

   en.wikipedia.org/wiki/List_of_abbreviations_used...

   twice daily bib. bibe: drink bis bis: twice b.i.d., b.d. bis in die: twice daily AMA style avoids use of this abbreviation (spell out "twice a day") bis ind. bis indies: twice a day bis in 7 d. bis in septem diebus: twice a week BM bowel movement: commonly used in the United Kingdom when discussing blood sugar.

5. Gemigliptin - Wikipedia

   en.wikipedia.org/wiki/Gemigliptin

   After 24 weeks, the reduction from baseline for HbA1c was 0.81% for gemigliptin 25 mg twice a day (bid) and 0.77% for gemigliptin 50 mg qd, and the differences in the least square mean changes from baseline between groups (each group of gemigliptin-sitagliptin group) were −0.011% in gemigliptin 25 mg bid and 0.004% in gemigliptin 50 mg qd.

6. Pfizer drops twice-daily version of obesity pill over side ...

   www.aol.com/news/pfizer-pulls-plug-twice-daily...

   (Reuters) -Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with ...

7. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include SGLT2 inhibitors as a first line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease, cardiovascular disease or heart failure.

8. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Pfizer announced on Dec. 1 that it was discontinuing phase 3 clinical trials of the twice-daily version due to high rates of adverse side effects. While these were mostly mild, a large percentage ...

9. Review links 3 potentially-blinding eye conditions to GLP-1 ...

   www.aol.com/review-links-3-potentially-blinding...

   A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye ...